• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秘鲁利马实施 COVID-19 强制性封锁措施对阿尔茨海默病患者认知和神经精神症状的影响。

Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru.

机构信息

Department of Neurology, Peruvian Institute of Neurosciences, Lima, Peru.

Unit for the Diagnosis of Cognitive Impairment and Dementia Prevention, Peruvian Institute of Neurosciences, Lima, Peru.

出版信息

Curr Alzheimer Res. 2023;20(2):80-88. doi: 10.2174/1567205020666230417103216.

DOI:10.2174/1567205020666230417103216
PMID:37073648
Abstract

BACKGROUND

Neuropsychiatric symptoms (NPS) in patients with Alzheimer's disease (AD) worsened during the COVID-19 lockdowns, but their progression thereafter is unknown. We present the first longitudinal study tracking them before, during, and after restrictions.

OBJECTIVES

To describe the effect of the COVID-19 mandatory lockdowns on Cognitive and Neuropsychiatric symptoms in patients with Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD).

METHODS

Cohort of 48 patients with amnestic MCI and 38 with AD in Lima, Peru. They received three rounds of cognitive (RUDAS, CDR, M@T), behavioral (NPI), and functional (ADCS-ADL) assessments. We assessed the change in score means across the time points and for each domain of NPS and tracked the changes in individual patients.

RESULTS

RUDAS declined 0.9 (SD 1.0) from baseline to lockdown and 0.7 (SD 1.0) after restrictions. M@T declined 1.0 (SD 1.5) from baseline to lockdown and 1.4 (SD 2.0) after restrictions. CDR worsened in 72 patients (83.72%) from baseline to post-lockdown. NPI worsened by 10 (SD 8.3) from baseline to lockdown but improved by 4.8 (SD 6.4) after restrictions. Proportionally, 81.3% of all patients had worsened NPS during the lockdowns, but only 10.7% saw an increase thereafter. Improvement was statistically significant for specific NPS domains except hallucinations, delusions, and appetite changes. Anxiety, irritability, apathy, and disinhibition returned to baseline levels.

CONCLUSION

Following confinement, cognition continued to decline, but NPS demonstrated either stability or improvement. This highlights the role modifiable risk factors may have on the progression of NPS.

摘要

背景

在 COVID-19 封锁期间,阿尔茨海默病(AD)患者的神经精神症状(NPS)恶化,但此后的进展情况尚不清楚。我们首次进行了一项纵向研究,在限制之前、期间和之后对其进行跟踪。

目的

描述 COVID-19 强制性封锁对轻度认知障碍(MCI)和阿尔茨海默病(AD)患者认知和神经精神症状的影响。

方法

这是在秘鲁利马进行的一项队列研究,共纳入 48 例有记忆障碍的 MCI 患者和 38 例 AD 患者。他们接受了三轮认知(RUDAS、CDR、M@T)、行为(NPI)和功能(ADCS-ADL)评估。我们评估了每个 NPS 域的分数均值在时间点上的变化,并跟踪了个体患者的变化。

结果

RUDAS 从基线到封锁期下降了 0.9(SD 1.0),从封锁期到限制后下降了 0.7(SD 1.0)。M@T 从基线到封锁期下降了 1.0(SD 1.5),从封锁期到限制后下降了 1.4(SD 2.0)。CDR 在 72 名患者(83.72%)中从基线到封锁后恶化。NPI 从基线到封锁期增加了 10(SD 8.3),但在限制后改善了 4.8(SD 6.4)。从比例上看,81.3%的患者在封锁期间 NPS 恶化,但此后只有 10.7%的患者 NPS 增加。除幻觉、妄想和食欲变化外,特定 NPS 域的改善具有统计学意义。焦虑、易怒、冷漠和抑制恢复到基线水平。

结论

在禁闭之后,认知继续下降,但 NPS 表现出稳定或改善。这突出了可改变的风险因素在 NPS 进展中的作用。

相似文献

1
Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru.秘鲁利马实施 COVID-19 强制性封锁措施对阿尔茨海默病患者认知和神经精神症状的影响。
Curr Alzheimer Res. 2023;20(2):80-88. doi: 10.2174/1567205020666230417103216.
2
Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.秘鲁 SARS-COV-2 大流行期间阿尔茨海默病患者的神经精神症状。
Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211039089. doi: 10.1177/15333175211039089.
3
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.新冠疫情封锁期间西班牙阿尔茨海默病患者的神经精神症状和生活质量
Eur J Neurol. 2020 Sep;27(9):1744-1747. doi: 10.1111/ene.14339. Epub 2020 Jun 24.
4
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.神经精神症状与轻度认知障碍患者向阿尔茨海默病进展的风险。
J Alzheimers Dis. 2019;70(1):25-34. doi: 10.3233/JAD-190025.
5
Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.ADNI 多中心观察队列研究:脑淀粉样变与 AD 神经精神症状的发生率和频率的关系。
BMJ Open. 2019 Dec 18;9(12):e031947. doi: 10.1136/bmjopen-2019-031947.
6
Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer's disease.遗忘型轻度认知障碍和轻度阿尔茨海默病患者的神经精神症状严重程度的性别差异及其与临床人口学和心理社会因素的关系。
Aging Ment Health. 2020 Mar;24(3):431-438. doi: 10.1080/13607863.2018.1539834. Epub 2018 Dec 27.
7
The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.COVID-19 封锁对痴呆症或轻度认知障碍患者神经精神症状的影响:系统评价和荟萃分析。
Psychogeriatrics. 2022 May;22(3):402-412. doi: 10.1111/psyg.12810. Epub 2022 Feb 6.
8
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.轻度认知障碍和阿尔茨海默病痴呆患者的神经精神症状和脑形态。
Int Psychogeriatr. 2021 Nov;33(11):1217-1228. doi: 10.1017/S1041610221000934. Epub 2021 Aug 17.
9
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.轻度认知障碍和阿尔茨海默病患者的神经精神症状的流行情况及其与认知障碍的关系。
Curr Alzheimer Res. 2010 Sep;7(6):517-26. doi: 10.2174/156720510792231748.
10
Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.神经精神和认知症状在阿尔茨海默病临床谱中的表现:横断面和纵向关联。
Neurology. 2021 Sep 28;97(13):e1276-e1287. doi: 10.1212/WNL.0000000000012598. Epub 2021 Aug 19.

引用本文的文献

1
Neurologic symptoms following COVID-19 in Lima, Peru: a prospective longitudinal observational study.秘鲁利马新冠病毒病后的神经系统症状:一项前瞻性纵向观察研究。
Front Neurol. 2025 Jul 21;16:1524613. doi: 10.3389/fneur.2025.1524613. eCollection 2025.
2
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease.阿尔茨海默病神经精神症状的最新进展与未来展望
Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.
3
The impact of COVID-19 post-infection on the cognition of adults from Peru.新冠病毒感染后对秘鲁成年人认知能力的影响。
Front Psychol. 2024 Jun 25;15:1325237. doi: 10.3389/fpsyg.2024.1325237. eCollection 2024.
4
Mental health impact of the COVID-19 pandemic on patients with neurodegenerative diseases and perceived family caregiver burden in Lima, Peru.COVID-19 大流行对秘鲁利马的神经退行性疾病患者的心理健康的影响,以及患者家属的照护负担。
Brain Behav. 2024 Jan;14(1):e3361. doi: 10.1002/brb3.3361.